BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36046628)

  • 1. Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach.
    Baldelli E; Mandarano M; Bellezza G; Petricoin EF; Pierobon M
    Cell Rep Methods; 2022 Aug; 2(8):100271. PubMed ID: 36046628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
    Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
    J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
    VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
    Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.
    Baldelli E; Haura EB; Crinò L; Cress DW; Ludovini V; Schabath MB; Liotta LA; Petricoin EF; Pierobon M
    Proteomics Clin Appl; 2015 Oct; 9(9-10):928-37. PubMed ID: 25676683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.
    Kerr A; Eliason JF; Wittliff JL
    Adv Exp Med Biol; 2008; 617():377-84. PubMed ID: 18497061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer transcriptomes refined with laser capture microdissection.
    Lin J; Marquardt G; Mullapudi N; Wang T; Han W; Shi M; Keller S; Zhu C; Locker J; Spivack SD
    Am J Pathol; 2014 Nov; 184(11):2868-84. PubMed ID: 25128906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.
    Baldelli E; El Gazzah E; Moran JC; Hodge KA; Manojlovic Z; Bassiouni R; Carpten JD; Ludovini V; Baglivo S; Crinò L; Bianconi F; Dong T; Loffredo J; Petricoin EF; Pierobon M
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573384
    [No Abstract]   [Full Text] [Related]  

  • 9. Laser capture microdissection of epithelial cancers guided by antibodies against fibroblast activation protein and endosialin.
    Rupp C; Dolznig H; Puri C; Schweifer N; Sommergruber W; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
    Diagn Mol Pathol; 2006 Mar; 15(1):35-42. PubMed ID: 16531767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.
    Dat le T; Matsuo T; Yoshimaru T; Kakiuchi S; Goto H; Hanibuchi M; Kuramoto T; Nishioka Y; Sone S; Katagiri T
    Int J Oncol; 2012 May; 40(5):1455-69. PubMed ID: 22294041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser capture microdissection technology.
    Espina V; Heiby M; Pierobon M; Liotta LA
    Expert Rev Mol Diagn; 2007 Sep; 7(5):647-57. PubMed ID: 17892370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.
    Baldelli E; Bellezza G; Haura EB; Crinó L; Cress WD; Deng J; Ludovini V; Sidoni A; Schabath MB; Puma F; Vannucci J; Siggillino A; Liotta LA; Petricoin EF; Pierobon M
    Oncotarget; 2015 Oct; 6(32):32368-79. PubMed ID: 26468985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.
    Espina V; Wulfkuhle J; Liotta LA
    Clin Lab Med; 2009 Mar; 29(1):1-13. PubMed ID: 19389547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot characterization of human lung NSCLC by protein pathway activation mapping.
    Zupa A; Improta G; Silvestri A; Pin E; Deng J; Aieta M; Musto P; Nitti D; Mammano E; Liotta L; Belluco C; Wulfkuhle J; Petricoin E
    J Thorac Oncol; 2012 Dec; 7(12):1755-1766. PubMed ID: 23154546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.
    Kikuchi T; Daigo Y; Katagiri T; Tsunoda T; Okada K; Kakiuchi S; Zembutsu H; Furukawa Y; Kawamura M; Kobayashi K; Imai K; Nakamura Y
    Oncogene; 2003 Apr; 22(14):2192-205. PubMed ID: 12687021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer.
    Uchiyama M; Usami N; Kondo M; Mori S; Ito M; Ito G; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Minna JD; Shimokata K; Sekido Y
    Int J Cancer; 2003 Dec; 107(6):962-9. PubMed ID: 14601056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy.
    Hou J; Lambers M; den Hamer B; den Bakker MA; Hoogsteden HC; Grosveld F; Hegmans J; Aerts J; Philipsen S
    J Thorac Oncol; 2012 Jan; 7(1):105-14. PubMed ID: 22134068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of periostin isoform pattern in non-small cell lung cancer.
    Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
    Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.